1-1 of 1
John Catalono, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Results of a Phase II Open-Label, Randomized Study of the BH3 Mimetic Protein Navitoclax (ABT-263) with or without Rituximab for Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia

Herbert Eradat, MD, MS, Sebastian Grosicki, MD, PhD, John Catalono, MD, Walter Cosolo, MD, Irina Dyagil, Thomas J Kipps, MD, PhD, Beiyao Zheng, Sreeni Yalamanchili, Srikumar Sahasranaman, Deborah Hurst, MD, William Ho, MD, PhD, Halyna Pylypenko, MD
Journal: Blood
Blood (2012) 120 (21): 190.
https://doi.org/10.1182/blood.V120.21.190.190
Published: 2012